Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1799200

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1799200

Smart Implantable Pumps

PUBLISHED:
PAGES: 173 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Smart Implantable Pumps Market to Reach US$3.6 Billion by 2030

The global market for Smart Implantable Pumps estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Smart Perfusion Pumps, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Smart Micro Pumps segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$697.6 Million While China is Forecast to Grow at 5.3% CAGR

The Smart Implantable Pumps market in the U.S. is estimated at US$697.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$585.9 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Smart Implantable Pumps Market - Key Trends & Drivers Summarized

How Are Smart Implantable Pumps Transforming Chronic Disease Therapy?

Smart implantable pumps are revolutionizing the delivery of medications and therapeutic agents within the human body by providing programmable, precise, and continuous infusion capabilities. Unlike external or manual delivery methods, these miniature, biocompatible devices are surgically placed under the skin or within body cavities to ensure targeted, long-term treatment with minimal patient intervention. They are critical for managing chronic conditions such as pain, spasticity, diabetes, cancer, and cardiovascular diseases, where consistent dosing and responsiveness to physiological feedback are essential.

What differentiates smart implantable pumps from legacy systems is their integration with sensors, microprocessors, and wireless telemetry, enabling real-time adjustments, data logging, and clinician oversight. Patients no longer need to adhere to strict dosing schedules or tolerate the peaks and troughs of conventional drug regimens. Instead, these systems can titrate doses based on biological signals, improving therapeutic outcomes and reducing side effects. They also eliminate the need for frequent hospital visits, making them a linchpin of remote and personalized healthcare.

What Technologies Are Powering Next-Generation Implantable Delivery Systems?

The modern smart pump is a convergence of microelectromechanical systems (MEMS), wireless communication, low-power electronics, and biocompatible materials. MEMS technology enables miniaturization without compromising functionality, allowing pumps to be safely implanted and refilled through minimally invasive procedures. Some pumps are equipped with pressure and flow sensors that monitor infusion accuracy, detect occlusions, or adjust for changes in patient physiology.

Wireless telemetry allows two-way communication between the device and external readers or clinician interfaces, often via handheld programmers or Bluetooth-enabled smartphones. Physicians can remotely monitor dosage history, battery life, and device function-and even make dosing adjustments in real time. Rechargeable batteries, inductive charging technologies, and energy harvesting mechanisms are enabling longer device lifespans and fewer surgical interventions. Integration with cloud-based health platforms allows longitudinal data tracking for clinical decision support.

Where Are Smart Implantable Pumps Making the Most Clinical Impact?

These devices are delivering life-changing benefits in oncology, where continuous infusion of chemotherapeutics can increase tumor targeting while reducing systemic toxicity. In pain management, intrathecal drug delivery via smart pumps offers a powerful alternative to opioids, minimizing dependence and improving quality of life for patients with intractable pain. For spasticity in conditions like multiple sclerosis and cerebral palsy, smart baclofen pumps allow precise, targeted neuromodulation.

In diabetes care, while external insulin pumps dominate, implantable versions are gaining ground for long-term glucose management, especially when coupled with continuous glucose monitors (CGMs). Cardiology is another growing frontier, with smart pumps under development for the controlled delivery of anticoagulants, antihypertensives, and anti-arrhythmic agents. Additionally, investigational applications in neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, involve targeted intracranial delivery of therapeutics via implantable infusion systems.

The Growth in the Smart Implantable Pumps Market Is Driven by Several Factors…

The market is expanding rapidly due to rising global prevalence of chronic and lifestyle-related diseases requiring continuous or highly targeted therapy. Technological advancements in miniaturization, power management, telemetry, and drug reservoir materials are enhancing device longevity, safety, and responsiveness. Increasing demand for remote patient monitoring, hospital-at-home care models, and personalized treatment protocols is reinforcing the appeal of smart, autonomous delivery systems.

Furthermore, favorable reimbursement frameworks, regulatory support for digital therapeutics, and growing clinician familiarity with implantable devices are reducing adoption barriers. Collaborations between medtech firms, digital health platforms, and pharmaceutical companies are also fostering innovation in pump-enabled drug delivery models. As healthcare systems prioritize patient adherence, outcome-based care, and cost-effective chronic disease management, smart implantable pumps are poised to become a foundational element of next-generation therapeutics.

SCOPE OF STUDY:

The report analyzes the Smart Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Pump Type (Smart Perfusion Pumps, Smart Micro Pumps); Application (Pain Application, Spasticity Application, Cardiovascular Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson (other implants)
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP39353

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Smart Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Disease Management Needs Propels Demand for Implantable Drug Delivery Devices
    • Miniaturization and Biocompatibility Advancements Drive Adoption of Smart Implantable Pumps
    • Integration with Remote Monitoring Platforms Strengthens Case for Connected Drug Delivery Systems
    • Increased Use of Closed-Loop Systems in Diabetes Management Expands Addressable Market
    • Clinical Shift Toward Targeted and Personalized Therapies Spurs Smart Pump Innovation
    • Surge in Demand for Pain Management Solutions Drives Interest in Programmable Intrathecal Pumps
    • Expansion of Wearables and Implantables Ecosystems Supports Smart Pump Interoperability
    • Real-Time Data Feedback Loops Enable Adaptive Dosing and Improved Patient Outcomes
    • Improved Battery Life and Wireless Charging Capabilities Enhance Patient Comfort and Compliance
    • Remote Software Updates and Physician Control Platforms Drive Clinical Utility
    • Growth of Home-Based Infusion Therapy Creates Demand for Safe, Long-Term Implantable Delivery
    • Regulatory Support for Digital Therapeutics Encourages Smart Pump Innovation in Niche Therapies
    • Collaborations Between MedTech and Biopharma Firms Fuel Innovation in Combination Delivery Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Smart Perfusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Smart Perfusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Smart Micro Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Smart Micro Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Pain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spasticity Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Spasticity Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!